J 2017

Functional and structural characterisation of 5 missense mutations of the phenylalanine hydroxylase

PECIMONOVA, Martina, Emil POLAK, Frantisek CSICSAY, Kamila RÉBLOVÁ, Maja STOJILJKOVIC et. al.

Základní údaje

Originální název

Functional and structural characterisation of 5 missense mutations of the phenylalanine hydroxylase

Autoři

PECIMONOVA, Martina (703 Slovensko), Emil POLAK (703 Slovensko), Frantisek CSICSAY (703 Slovensko), Kamila RÉBLOVÁ (203 Česká republika, garant, domácí), Maja STOJILJKOVIC (688 Srbsko), Zdenko LEVARSKI (703 Slovensko), Ludovit SKULTETY (703 Slovensko), Ludevit KADASI (703 Slovensko) a Andrea SOLTYSOVA (703 Slovensko)

Vydání

General physiology and biophysics, BRATISLAVA, General Physiol and Biophysic, 2017, 0231-5882

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10600 1.6 Biological sciences

Stát vydavatele

Slovensko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 1.479

Kód RIV

RIV/00216224:14740/17:00098089

Organizační jednotka

Středoevropský technologický institut

UT WoS

000412155000001

Klíčová slova anglicky

PAH mutations; Phenylketonuria; Specific activity; Chaperons; Functional study

Štítky

Změněno: 30. 10. 2017 15:45, Mgr. Eva Špillingová

Anotace

V originále

Phenylketonuria (PKU) and hyperphenylalaninemia (HPA) are a group of genetic disorders predominantly caused by mutations in the phenylalanine hydroxylase (PAH) gene. To date, more than 950 variants have been identified, however the pathogenic mechanism of many variants remains unknown. In this study, in silico prediction and in vitro prokaryotic and eukaryotic expression systems were used to functionally characterise five PAH missense variants (p.F233I, p.R270I, p.F331S, p.S350Y, and p.L358F) previously identified in Slovak and Czech patients. p.F233I, p.R270I, and p.S350Y were classified as deleterious mutations since they showed no specific activity in functional assay and no response to chaperone co-expression. Protein levels of these PAH variants were very low when expressed in HepG2 cells, and only p.S350Y responded to BH4 precursor overload by significant increase in PAH monomer, probably due to reduced rate of protein degradation as the result of proper protein folding. Variants p.F331S and p.L358F exerted residual enzymatic activity in vitro. While the first can be classified as probably pathogenic due to its very low protein levels in HepG2 cells, the latter is considered to be mild mutation with protein levels of approximately 17.85% compared to wt PAH. Our findings contribute to better understanding of structure and function of PAH mutated enzymes and optimal treatment of PKU patients carrying these mutations using BH4 supplementation.

Návaznosti

LM2015085, projekt VaV
Název: CERIT Scientific Cloud (Akronym: CERIT-SC)
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CERIT Scientific Cloud
LQ1601, projekt VaV
Název: CEITEC 2020 (Akronym: CEITEC2020)
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CEITEC 2020